Basta James (CIK 0001792726)

Latest company ownership

NTLA - Intellia Therapeutics, Inc.

Role: EVP, General Counsel

Shares held

57,143

Last filed at

Mar 4, 2025

Confidence Score

50.4

2025Q4

Confidence Score History

2023Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Mar 1, 2025	Mar 4, 2025	Intellia Therapeutics, Inc.	EVP, General Counsel	Sell	91.3	+37,428	50.24%	✗	$23.1K
Jan 3, 2025	Jan 7, 2025	Intellia Therapeutics, Inc.	EVP, General Counsel	Sell	42.5	-7,074	-8.67%	✗	$86.2K
Mar 1, 2024	Mar 5, 2024	Intellia Therapeutics, Inc.	EVP, General Counsel	Sell	95.0	+30,097	58.47%	✗	$75.8K
Jan 3, 2024	Jan 5, 2024	Intellia Therapeutics, Inc.	EVP, General Counsel	Sell	42.5	-3,805	-6.88%	✗	$112.1K
Mar 1, 2023	Mar 3, 2023	Intellia Therapeutics, Inc.	EVP, General Counsel	Sell	91.3	+35,720	182.63%	✗	$47.7K
Jan 4, 2023	Jan 6, 2023	Intellia Therapeutics, Inc.	EVP, General Counsel	Sell	46.3	-1,138	-5.50%	✗	$42.3K